A LinkedIn post from Acclaro Medical highlights increasing utilization of its UltraClear® laser platform at West End MedSpa in Rochester, Minnesota. According to the post, the clinic has expanded into a 13,000 square foot facility and added a second UltraClear device in response to patient demand and reported treatment results.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests growing traction for Acclaro Medical’s fiber‑based UltraClear technology within the medical aesthetics segment. For investors, this example of repeat equipment adoption at an existing customer may indicate rising procedure volumes and potential for recurring consumables or service revenue, while also signaling competitive positioning as clinics scale capacity.

